Atlas Trials

A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan

Clinical trial NCT04070313 · TERMINATED

Trial details

NCT number
NCT04070313
Sponsor
TTY Biopharm
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Resected Pancreatic CancerPancreatic CancerAdjuvant Chemotherapy
Start date
2019-07-11
Primary completion
2021-10-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.